Home
Lasse Gunnar Gøransson's picture

Lasse Gunnar Gøransson

Professor
  • E-mailLasse.Goransson@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Klotho and Fibroblast Growth Factor 23 Are Independent of Vitamin D, and Unlike Vitamin D, Are Not Associated With Graft- and Patient Survival After Kidney Transplantation. Transplantation direct. 8 pages.
  • Show author(s) (2023). Glycated albumin and post-transplant diabetes mellitus in kidney transplant recipients. Annals of Clinical Biochemistry. 109-116.
  • Show author(s) (2022). Glycated albumin in pregnancy: LC-MS/MS-based reference interval in healthy, nulliparous Scandinavian women and its diagnostic accuracy in gestational diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 123-131.
  • Show author(s) (2022). Glycated albumin and continuous glucose monitoring metrics across pregnancy in women with pre-gestational diabetes. Endocrinology, Diabetes & Metabolism.
  • Show author(s) (2022). En mann i 50-årene med smerter i hode, nakke og øregang. Tidsskrift for Den norske legeforening. 1-11.
  • Show author(s) (2021). The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI. International journal of cardiology: Heart and Vasculature (IJCHA). 1-6.
  • Show author(s) (2021). Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus. Journal of Neurology. 11 pages.
  • Show author(s) (2020). Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome. Journal of Neurology. 10 pages.
  • Show author(s) (2020). Health literacy in kidney disease: associations with quality of life and adherence. Journal of Renal Care. 85-94.
  • Show author(s) (2020). Exploring health literacy in patients with chronic kidney disease: a qualitative study. BMC Nephrology. 1-9.
  • Show author(s) (2019). Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study. Clinical Transplantation. 1-12.
  • Show author(s) (2019). Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia). Clinical Nephrology. 246-253.
  • Show author(s) (2019). Lilla urinpose-syndrom. Tidsskrift for Den norske legeforening. 534-544.
  • Show author(s) (2019). A cross-sectional study of health literacy in patients with chronic kidney disease: Associations with demographic and clinical variables. Nursing Open. 1481-1490.
  • Show author(s) (2018). The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome. Lupus. 2101-2111.
  • Show author(s) (2018). Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study. Transplantation direct. 1-7.
  • Show author(s) (2017). The impact of calcineurin inhibitors on neutrophil gelatinase-associated lipocalin and fibroblast growth factor 23 in long-term kidney transplant patients. Clinical Transplantation. 1-6.
  • Show author(s) (2017). Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genetics. 1-29.
  • Show author(s) (2017). Glycemic control and complications in patients with type 1 diabetes – a registry-based longitudinal study of adolescents and young adults. Pediatric Diabetes. 188-195.
  • Show author(s) (2016). Treningsutløst rabdomyolyse – en ny tendens? Tidsskrift for Den norske legeforening. 1537-1541.
  • Show author(s) (2016). Neutrophil gelatinase-associated lipocalin, fibroblast growth factor 23, and soluble klotho in long-term kidney donors. Nephron Extra. 31-39.
  • Show author(s) (2016). Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies. European Journal of Neurology. 780-786.
  • Show author(s) (2015). The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 582-596.
  • Show author(s) (2015). Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients. European Journal of Endocrinology (EJE). 343-350.
  • Show author(s) (2015). Fatigue in Newly Diagnosed Inflammatory Bowel Disease. Journal - Crohn's and Colitis Foundation of Canada. 725-730.
  • Show author(s) (2015). Benchmarking by HbA1c in a national diabetes quality register - does measurement bias matter? Clinical Chemistry and Laboratory Medicine. 1433-1439.
  • Show author(s) (2014). Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clinical Transplantation. 479-486.
  • Show author(s) (2014). Loss of cerebral white matter in primary Sjögren's syndrome: a controlled volumetric magnetic resonance imaging study. European Journal of Neurology. 1324-1329.
  • Show author(s) (2014). High headache-related disability in patients with systemic lupus erythematosus and primary Sjögren's syndrome. European Journal of Neurology. 1124-1130.
  • Show author(s) (2014). Association of hippocampal atrophy with cerebrospinal fluid antibodies against the nr2 subtype of the N-methyl- D -aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome. Arthritis and Rheumatism. 3387-3394.
  • Show author(s) (2014). A possible genetic association with chronic fatigue in primary Sjögren’s syndrome: a candidate gene study. Rheumatology International. 191-197.
  • Show author(s) (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 1284-1292.
  • Show author(s) (2013). Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study. Arthritis Care and Research. 816-821.
  • Show author(s) (2013). Memory dysfunction in Primary Sjögren’s Syndrome is associated with anti-NR2 antibodies. Arthritis and Rheumatism. 3209-3217.
  • Show author(s) (2013). Health-related quality of life in kidney transplant patients and non-renal replacement therapy patients with chronic kidney disease stages 3b-4. Annals of Transplantation. 635-642.
  • Show author(s) (2013). Headache in primary Sjøgren's syndrome: a population-based retrospective cohort study. European Journal of Neurology. 558-563.
  • Show author(s) (2012). The risk of Non-Hodgkin Lymphoma in Primary Sjögren's Syndrome, a population-based study. Arthritis Care and Research.
  • Show author(s) (2012). Prevalence of diabetic retinopathy in Norway: report from a screening study. Acta Ophthalmologica.
  • Show author(s) (2012). Oxidative stress, as measured by protein oxidation, is increased in primary Sjögren's syndrome. Free radical research. 141-146.
  • Show author(s) (2012). Interleukin-1 inhibition and fatigue in primary Sjögren's Syndrome - a double blind, randomised clinical trial. PLOS ONE. 429-435.
  • Show author(s) (2012). Improved detection of advanced oxidation protein products in plasma. Clinica Chimica Acta. 901-906.
  • Show author(s) (2012). Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial. BMC Nephrology. 8 pages.
  • Show author(s) (2011). The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology. 221-224.
  • Show author(s) (2011). Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-infl ammatory fatty acid index – a pilot study. Scandinavian Journal of Clinical and Laboratory Investigation. 68-73.
  • Show author(s) (2011). Migraine is frequent in patients with systemic lupus erythematosus: A case-control study. Cephalalgia. 401-408.
  • Show author(s) (2011). Intact parathyroid hormone levels in renal transplant patients with normal transplant function. Clinical Transplantation. E566-E570.
  • Show author(s) (2011). Crescentic glomerulonephritis and microangiopathic haemolytic anaemia in a patient with established systemic sclerosis. Scandinavian Journal of Urology and Nephrology. 470-472.
  • Show author(s) (2011). Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes and Immunity. 100-109.
  • Show author(s) (2010). No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine. 175-180.
  • Show author(s) (2009). The Nephrocare project: Referral, patient case-mix, follow-up and quality of renal care in Nordic renal centres. Scandinavian Journal of Urology and Nephrology. 319-324.
  • Show author(s) (2009). Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Annals of the Rheumatic Diseases. 1541-1546.
  • Show author(s) (2009). Fatigue in primary Sjogren's syndrome - A link to sickness behaviour in animals? Brain, Behavior, and Immunity. 1104-1108.
  • Show author(s) (2009). Cerebral white matter hyperintensities are not increased in patients with primary Sjögren's syndrome. European Journal of Neurology. 576-581.
  • Show author(s) (2008). Lntravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality. Scandinavian Journal of Rheumatology. 130-134.
  • Show author(s) (2008). Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. Journal of Neurology, Neurosurgery and Psychiatry. 199-201.
  • Show author(s) (2007). Renal transplant and secondary hyperparathyroidism. Scandinavian Journal of Urology and Nephrology. 553-557.
  • Show author(s) (2006). Small-diameter nerve fiber neuropathy in systemic lupus erythematosus. Archives of Neurology. 401-404.
  • Show author(s) (2006). Peripheral neuropathy in primary Sjogren syndrome - A population-based study. Archives of Neurology. 1612-1615.
  • Show author(s) (2006). Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Archives of Neurology. 1410-1413.
  • Show author(s) (2004). The effect of age and gender on epidermal nerve fiber density. Neurology. 774-777.
  • Show author(s) (2001). Consequences of late referral of patients with end-stage renal disease. Journal of Internal Medicine. 154-159.
Academic lecture
  • Show author(s) (2006). Small-diameter nerve fiber neuropathy in patients with autoimmune disease. Plenary talk and abstract at the Sandnes, Norway 16th - 17th June, 2006.
  • Show author(s) (2002). The variability of epidermal nerve fiber densities in healthy individuals.
  • Show author(s) (2002). Determination of epidermal nerve fiber density. Methodological issues.
Popular scientific article
  • Show author(s) (2015). Antikoagulasjon vid hemodialyse. Endred prosedyre reduserte dosen. Dialasen. 24-26.
Letter to the editor
  • Show author(s) (2021). Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up! Transplantation. E80-E81.
  • Show author(s) (2019). Systemic capillary leak syndrome following bosentan treatment in a patient with systemic sclerosis. Scandinavian Journal of Rheumatology. 426-427.
  • Show author(s) (2015). Reply. Arthritis & Rheumatology. 1683-1684.
Doctoral dissertation
  • Show author(s) (2006). Small-diameter nerve fiber neuropathy in patients with systemic autoimmune diseases.
Abstract
  • Show author(s) (2010). Prevalence of primary Sjogren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology. 36-36.
  • Show author(s) (2010). Pattern of mild cognitive impairment in patients with primary Sjogren's syndrome as compared to patients with SLE. Journal of Neuroimmunology. 185-186.
  • Show author(s) (2005). The spectrum of peripheral neuropathy in primary Sjögren's syndrome. Journal of the peripheral nervous system. 28-28.
  • Show author(s) (2005). The spectrum of peripheral neuropathy in primary Sjogren's syndrome. Journal of the peripheral nervous system.
  • Show author(s) (2005). A selective loss of small-diameter nerve fibers in systemic lupus erythematosus. Journal of the peripheral nervous system.
  • Show author(s) (2004). Small-fiber neuropathy in systemic lupus erythematosus. Journal of Neuroimmunology. 146.
Poster
  • Show author(s) (2018). Health literacy in patients With Chronic Kidney Disease: Associations With self-reported adherence to long-term therapy.
  • Show author(s) (2018). Health literacy in patients With CKD stages 3-5.
  • Show author(s) (2015). Hemodialyse og antiokoagulasjon.
  • Show author(s) (2013). Health related quality of life in patients with chronic kidney disease. Kidney transplanted vs. non-transplanted patients.
  • Show author(s) (2009). Prevalence of primary Sjögren's syndrome in two Norwegian counties.
  • Show author(s) (2009). Association of C8orf13-BLK and TNFSF4 Gene Variants with Primary Sjögren's Syndrome.
Academic literature review
  • Show author(s) (2007). Primary Sjögren´s Syndrome Associated Neuropathy. Canadian Journal of Neurological Sciences (CJNS). 280-287.

More information in national current research information system (CRIStin)